Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Ross

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Immunology|March 1, 1984
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1)N Hogg, G D Ross, D B Jones, et al.
Blood|March 1, 1988
Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3bM S Currie, P K Rustagi, R Wojcieszak, et al.
Clinical and Experimental Immunology|March 1, 1985
Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inheritedM J Walport, G D Ross, C Mackworth-Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1977
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiationR J Winchester, G D Ross, C I Jarowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)J Yan, V Vetvicka, Y Xia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3dL M Hutt-Fletcher, E Fowler, J D Lambris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.
The Journal of Experimental Medicine|August 1, 1983
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininG D Ross, S L Newman, J D Lambris, et al.
Leukemia|July 31, 2004
Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cellsM Z Ratajczak, R Reca, M Wysoczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregationJ P Buyon, S B Abramson, M R Philips, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Immunology|March 1, 1984
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1)N Hogg, G D Ross, D B Jones, et al.
Blood|March 1, 1988
Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3bM S Currie, P K Rustagi, R Wojcieszak, et al.
Clinical and Experimental Immunology|March 1, 1985
Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inheritedM J Walport, G D Ross, C Mackworth-Young, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1977
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiationR J Winchester, G D Ross, C I Jarowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18)J Yan, V Vetvicka, Y Xia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3dL M Hutt-Fletcher, E Fowler, J D Lambris, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.
The Journal of Experimental Medicine|August 1, 1983
Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutininG D Ross, S L Newman, J D Lambris, et al.
Leukemia|July 31, 2004
Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cellsM Z Ratajczak, R Reca, M Wysoczynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Dissociation between increased surface expression of gp165/95 and homotypic neutrophil aggregationJ P Buyon, S B Abramson, M R Philips, et al.
Pageof 8